CAPPED BONUSZERTIFIKAT - MERCK & CO. Share Price

Certificat

DE000PC67NB9

Market Closed - Börse Stuttgart 01:24:01 17/05/2024 pm IST
115.7 EUR -0.47% Intraday chart for CAPPED BONUSZERTIFIKAT - MERCK & CO.
Current month-0.45%
1 month+1.52%
Date Price Change
17/24/17 115.7 -0.47%
16/24/16 116.3 +0.57%
15/24/15 115.6 -0.25%
14/24/14 115.9 -0.51%
13/24/13 116.5 +0.29%

Delayed Quote Börse Stuttgart

Last update May 17, 2024 at 01:24 pm IST

More quotes

Static data

Product typeCertificati Bonus e Protezione parz.
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC67NB
ISINDE000PC67NB9
Date issued 25/03/2024
Strike 140 $
Maturity 20/06/2025 (397 Days)
Parity 1 : 1
Emission price 109.1
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 116.8
Lowest since issue 111.4
Spread 0.02
Spread %0.02%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
131.2 USD
Average target price
141.6 USD
Spread / Average Target
+7.96%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW